Modifying Effects of Ethinylestradiol but Not Methoxychlor on N-Ethyl-N-nitrosourea-Induced Uterine Carcinogenesis in Heterozygous p53-Deficient CBA Mice
| Autor: | Masao Hirose, Hiroshi Onodera, Toru Tamura, Yasuji Aoki, Hisayoshi Takagi, Kunitoshi Mitsumori, Osamu Nagata, Kazuo Yasuhara, Takeo Shimo |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
medicine.medical_specialty
Sarcoma Endometrial Stromal medicine.medical_treatment Intraperitoneal injection Uterus Biology Ethinyl Estradiol Toxicology Immunoenzyme Techniques Mice chemistry.chemical_compound Proliferating Cell Nuclear Antigen Ethinylestradiol Internal medicine medicine Animals Mice Knockout Cocarcinogenesis Body Weight Drug Synergism Methoxychlor Organ Size Genes p53 medicine.disease Diet Endometrial Neoplasms Endometrial hyperplasia Endocrinology medicine.anatomical_structure chemistry In utero Ethylnitrosourea Endometrial Hyperplasia Toxicity Carcinogens Mice Inbred CBA Adenocarcinoma Female Injections Intraperitoneal Adenocarcinoma Clear Cell medicine.drug |
| Zdroj: | Toxicological Sciences. 58:43-49 |
| ISSN: | 1096-0929 |
| Popis: | It is unknown whether endocrine-disrupting chemicals (EDCs) with estrogenic activities have any modifying effects on uterine carcinogenesis. In our previous study, we established a uterine-carcinogenesis model that is useful for detecting tumor-modifying effects of EDCs by the administration of N-ethyl-N-nitrosourea (ENU) to female heterozygous p53-deficient CBA mice [p53 (+/-) mice]. To investigate the effects of ethinylestradiol (EE) and methoxychlor (MXC) on development of ENU-induced uterine tumors, female p53 (+/-) mice and their wild-type littermates [p53 (+/+) mice] received an intraperitoneal injection of 120 mg/kg body weight (bw) of ENU, followed, in Group 1, by no further treatment; in Group 2, by a diet containing 1 ppm EE; in Group 3, by a diet containing 5 ppm EE for 4 weeks and 2.5 ppm EE thereafter; and in Group 4, by a diet containing 2000 ppm MXC for 26 weeks. Uterine proliferative lesions that were induced were composed of both endometrial-stromal and epithelial-cell types. Endometrial stromal sarcomas were induced in p53 (+/-) mice of Groups 1 to 4, and the incidence (87%) in Group 3 was significantly increased compared to Group 1 (47%). Atypical hyperplasias (clear-cell type) of the endometrial gland in p53 (+/-) mice were seen at incidences of 0, 14, 60, and 0% in Groups 1, 2, 3, and 4, respectively, while their incidence in p53 (+/+) mice was 0, 7, 53, and 0%, respectively, with a significant difference between Groups 1 and 3 in both cases. One p53 (+/-) mouse in Group 3 also had an adenocarcinoma consisting of clear cells, and the PCNA labeling indices of the clear-cell atypical hyperplasias, and this endometrial adenocarcinoma, were higher than those of glandular hyperplasias. The present study suggests that 2.5 ppm EE, but not MXC, exerts tumor-promoting effects on stromal and epithelial proliferative lesions of the uteri in p53 (+/-) mice initiated with ENU. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|